Department of Endocrinology and Metabolism, National Research Institute for Child Health and Development, 2-10-1 Ohkura, Setagaya, Tokyo 157-8535, Japan.
J Clin Endocrinol Metab. 2010 Feb;95(2):756-64. doi: 10.1210/jc.2009-1334. Epub 2009 Dec 4.
Although recent studies have suggested a positive role of OTX2 in pituitary as well as ocular development and function, detailed pituitary phenotypes in OTX2 mutations and OTX2 target genes for pituitary function other than HESX1 and POU1F1 remain to be determined.
We aimed to examine such unresolved issues.
We studied 94 Japanese patients with various ocular or pituitary abnormalities.
We identified heterozygous p.K74fsX103 in case 1, p.A72fsX86 in case 2, p.G188X in two unrelated cases (3 and 4), and a 2,860,561-bp microdeletion involving OTX2 in case 5. Clinical studies revealed isolated GH deficiency in cases 1 and 5; combined pituitary hormone deficiency in case 3; abnormal pituitary structures in cases 1, 3, and 5; and apparently normal pituitary function in cases 2 and 4, together with ocular anomalies in cases 1-5. The wild-type Orthodenticle homeobox 2 (OTX2) protein transactivated the GNRH1 promoter as well as the HESX1, POU1F1, and IRBP (interstitial retinoid-binding protein) promoters, whereas the p.K74fsX103-OTX2 and p.A72fsX86-OTX2 proteins had no transactivation functions and the p.G188X-OTX2 protein had reduced ( approximately 50%) transactivation functions for the four promoters, with no dominant-negative effect. cDNA screening identified positive OTX2 expression in the hypothalamus.
The results imply that OTX2 mutations are associated with variable pituitary phenotype, with no genotype-phenotype correlations, and that OTX2 can transactivate GNRH1 as well as HESX1 and POU1F1.
尽管最近的研究表明 OTX2 在垂体以及眼部发育和功能中具有积极作用,但 OTX2 突变以及除 HESX1 和 POU1F1 之外影响垂体功能的 OTX2 靶基因在垂体中的详细表型仍有待确定。
我们旨在研究这些尚未解决的问题。
我们研究了 94 名具有各种眼部或垂体异常的日本患者。
我们在 1 号病例中发现了杂合子 p.K74fsX103,在 2 号病例中发现了 p.A72fsX86,在两个无关病例(3 号和 4 号)中发现了 p.G188X,在 5 号病例中发现了涉及 OTX2 的 2860561bp 微缺失。临床研究显示 1 号和 5 号病例为单纯性 GH 缺乏症;3 号病例为垂体激素联合缺乏症;1 号、3 号和 5 号病例为垂体结构异常;2 号和 4 号病例为垂体功能明显正常,1 号至 5 号病例均伴有眼部异常。野生型 Orthodenticle homeobox 2 (OTX2) 蛋白可转激活 GnRH1 启动子以及 HESX1、POU1F1 和 IRBP(间质视黄醇结合蛋白)启动子,而 p.K74fsX103-OTX2 和 p.A72fsX86-OTX2 蛋白则没有转激活功能,p.G188X-OTX2 蛋白的转激活功能降低(约 50%),对四个启动子均无显性负效应。cDNA 筛选鉴定了下丘脑的 OTX2 表达阳性。
研究结果表明,OTX2 突变与可变的垂体表型相关,无基因型-表型相关性,OTX2 可转激活 GnRH1 以及 HESX1 和 POU1F1。